CHRISTOPHER DE LA PAZ: Open Payments
NPI 1669026738 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,309 in 23 payments from 11 companies in 2025. Trend: 2023 $502 · 2024 $1,032 · 2025 $1,309
Food & beverage: $1,138Education: $171
| Company | Payments | Amount |
|---|---|---|
| BeOne Medicines USA, Inc. | 3 | $271 |
| SANOFI-AVENTIS U.S. LLC | 5 | $172 |
| Astellas Pharma US Inc | 2 | $171 |
| Janssen Biotech, Inc. | 3 | $144 |
| Incyte Corporation | 2 | $143 |
| BeiGene USA, Inc. | 1 | $125 |
| Karyopharm Therapeutics Inc. | 1 | $117 |
| Daiichi Sankyo Inc. | 3 | $75 |
| Legend Biotech USA Inc. | 1 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
Products named: BRUKINSA, REZUROCK, NIKTIMVO, RYBREVANT, XPOVIO, TEVIMBRA, Vanflyta, CARVYKTI.
Industry payments across FL — which companies pay providers there.
